share_log

Spero Therapeutics | 8-K: Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

SEC ·  Aug 6 04:20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.